Bayesian designs for phase I-II clinical trials /
| Main Authors: | , , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Boca Raton :
CRC Press,
2016.
|
| Series: | Chapman & Hall/CRC biostatistics series.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Why conduct phase I-II trials?
- The phase I-II paradigm
- Establishing priors
- Efficacy : toxicity trade-off-based designs
- Designs with late-onset outcomes
- Utility-based designs
- Personalized dose finding
- Combination trials
- Optimizing molecularly targeted agents
- Optimizing doses in two cycles
- Optimizing dose and schedule
- Dealing with dropouts
- Optimizing intra-arterial tPA
- Optimizing sedative dose in preterm infants.